COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
- PMID: 32276139
- PMCID: PMC7139268
- DOI: 10.1016/j.clim.2020.108413
COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
Abstract
Clusters of patients with novel coronavirus disease 2019 (COVID-19) have been successively reported globally. Studies show clear person-to-person transmission. The average incubation period is 2-14 days, and mostly 3-7 days. However, in some patients, this period may be longer. Here, we report a familial cluster of COVID-19 where a 47-year-old woman with long-term use of glucocorticoids did not develop any symptoms within the 14-day quarantine period but was confirmed with COVID-19 by tested positive of antibody on day 40 after she left Wuhan. Almost at the same time, her father and sister were diagnosed with COVID-19. The results suggest that the long-term use of glucocorticoids might cause atypical infections, a long incubation period, and extra transmission of COVID-19.
Keywords: Atypical infection; COVID-19; Familial cluster; Immunocompromised; Incubation period; Shedding duration.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest We declare no competing interests.
Figures


References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical